1. ホーム
  2. プレゼンテーション
  3. 4503 アステラス製薬株式会社

Astellas Pharma Inc.

Code
4503
Market
TYO1
Category of Business
Pharmaceuticals

Information Meeting for Institutional Investors and Analysts

2022年8月 1日

Astellas Earnings Call -Q1/FY2022 Financial Results -

Chief Financial Officer (CFO) Minoru Kikuoka
Chief Medical Officer (CMO) Bernhardt Zeiher, M.D.
Chief Commercial Officer (CCO) Yukio Matsui
presentation material
2022年4月27日

FY2021 financial Results ended March 31, 2022

President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
Chief Medical Officer (CMO) Bernhardt Zeiher, M.D.
Chief Commercial Officer (CCO) Yukio Matsui
Chief Financial Officer (CFO) Minoru Kikuoka
presentation material
2022年3月 9日

R&D Meeting -Initiatives for Gene Therapy-

President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
Division Head of Gene Therapy Research & Technical Operations Mathew Pletcher, Ph.D.
Chief Medical Officer (CMO) Bernhardt Zeiher, M.D., FACP, FCCP
Chief Strategy Officer (CStO) and Chief Business Officer (CBO) Naoki Okamura
Chief Scientific Officer (CScO) Yoshitsugu Shitaka, Ph.D.
presentation material
2022年2月28日

Sustainability Meeting

Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
Chief Administrative Officer (CAO) and Chief Ethics & Compliance Officer (CECO) Fumiaki Sakurai
Vice President, Sustainability, Corporate Advocacy Shingo Iino, Ph.D.
presentation material
2022年2月 2日

Astellas Earnings Call -Financial Results for the Q3 of FY2021-

Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
Chief Commercial Officer (CCO) Yukio Matsui
Senior Vice President, Development Project Management Head Minetake Kitagawa
presentation material
2021年12月 7日

R&D meeting -New research organization structure -

Representative Director, Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
Chief Scientific Officer(CScO) Yoshitsugu Shitaka, Ph.D.
presentation material
2021年10月29日

Astellas Earnings Call -Financial Results for the Q2 of FY2021-

Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
Representative Director, Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
Chief Medical Officer (CMO) Bernhardt Zeiher, M.D.
Chief Commercial Officer (CCO) Yukio Matsui
presentation material
2021年5月26日

CSP2021(CSP: Corporate Strategic Plan)

Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
Representative Director, Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO) Naoki Okamura
Chief Medical Officer (CMO) Bernhardt Zeiher, M.D.
presentation material
2021年3月25日

Rx+ Day

Executive Vice President, Chief Strategy Officer and Chief Financial Officer
Naoki Okamura
Senior Vice President,RX + Business Accelerator
Yuta Watanabe
Business Producer,Rx+ Business Accelerator
Akira Suwa
Business Producer,Rx+ Business Accelerator
Motohiro Kanayama
Principal, Project Lead, Digital Health, Rx+ Business Accelerator
Naoyuki Kanda
Business Producer, Rx+ Business Accelerator
Makoto Ogino
Business Producer,Rx+ Business Accelerator
Kunitake Abe
presentation material